Exosens share falls 1.5% and loses SBF 120 leadership after two wild trading sessions

Invest Securities raises its target to €70 following annual target revision

The brokerage Invest Securities updated its opinion on Exosens on Monday, September 21, maintaining its buy rating while raising its price target from €67 to €70. This represents an upside potential of just over 16% compared to the current price. This revision follows the two strong trading sessions recorded following the publication of new annual targets on September 17, when the company projected approximately 20% growth in revenue (up to €570 million) and around 25% growth in adjusted EBITDA for 2026.

The share surged nearly 10% that day, then gained an additional 3.5% on September 18, posting the best performance of the SBF 120 in that session. Today's correction, modest compared to these two jumps, appears more like a consolidation of the move than a trend reversal, especially since the weekly gain remains above 9%.

Solid technical configuration despite today's decline and trailing position in SBF 120

Exosens is trading at €59.85 in today's session, placing it among the biggest decliners in the SBF 120 with a drop of 1.64%. Despite this decline, the moving average configuration remains favorable: the stock is holding above its three reference moving averages, with a spread of 3.82% above the 20-day MA (€57.65) and 1.29% above the 200-day MA (€59.09). The 50-day MA at €59.54 is nearly touching the current price, making it the most immediate moving average level to watch if the decline continues.

The RSI at 58 reflects a neutral to slightly bullish configuration, with no overbought signal despite the two consecutive up sessions last week. The identified support at €54.15 remains nearly 10% away from the current price, while resistance at €66.80 roughly corresponds to Invest Securities' revised target. The nine-month results, expected on October 27, will constitute the next key reference point to measure progress toward the revised annual targets.